Considering the existing challenges to hospital-based maternity care in rural areas and the potential for it to worsen, this data note analyzes the availability of hospitals providing inpatient maternity care in rural areas for Medicaid enrollees and illustrates how access to these services could be affected if additional rural hospitals were to close or eliminate…
This brief describes Trump Administration efforts to scale back or modify data collection on sexual orientation and gender identity variables in federal surveys. It specifically focuses on changes in three national surveys that are representative of these efforts: the National Health Interview Survey (NHIS), the Medicare Current Beneficiary Survey (MCBS), and the National Crime Victimization…
By GEORGE HALVORSON Special Needs Plans Change Lives for The Lowest Income and Highest Need Patients The people who benefit the most from Medicare Advantage are clearly the very low-income and high health-need people who are eligible for both Medicare and Medicaid as programs and who enroll as members in the Medicare Advantage Special Needs…
By KIM BELLARD Over the years, one area of tech/health tech I have avoided writing about are brain-computer interfaces (B.C.I.). In part, it was because I thought they were kind of creepy, and, in larger part, because I was increasing finding Elon Musk, whose Neuralink is one of the leaders in the field, even more…
Alanys Ortiz reads Josephine Senek’s cues before she speaks. Josephine, who lives with a rare and debilitating genetic condition, fidgets her fingers when she’s tired and bites the air when something hurts. Josephine, 16, has been diagnosed with tetrasomy 8p mosaicism, severe autism, severe obsessive-compulsive disorder, and attention-deficit/hyperactivity disorder, among other conditions, which will require…
It’s not a mystery — it’s a flaw in how knowledge is managed, where the greatest discoveries are hidden by the friction between what we already know and what we can find. Fixing it does not require more data; it requires systems capable of understanding the data. The post The $10 Million Problem in Every…
Novartis is getting global rights to a Monte Rosa Therapeutic molecular glue degrader drug in early clinical testing as a potential treatment for autoimmune disorders. The deal comes months after the pharma giant landed rights to an Arvinas targeted protein degrader for cancer. The post Novartis to Pay $150M for Monte Rosa Glue Drug in…
Mehmet Oz shared CMS’s perspective on AI, faster innovation, prior authorization
By MICHAEL MILLENSON Shared decision-making between doctors and patients may be “the pinnacle of patient-centered care,” but three new medical journal articles suggest it’s encountering more problems than peaks. Yet counterintuitively, it may be artificial intelligence that rescues this intimately human interaction. “Shared decision-making is at a crossroads,” declares a Perspective in the Journal of General…
Merida Biosciences is developing antibody-like drugs designed to selectively eliminate disease-driving autoantibodies while sparing healthy components of the immune system. Graves disease, which stems from the immune system’s attack on the thyroid gland, is the startup’s lead disease target. The post Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease appeared…